Anti-AD drugs, especially piracetam could significantly reduce some diabetic parameters, such as fasting plasma glucose (FPG), HbA1c, and serum insulin concentration in patients with diabetic AD (34). The gene discussed is INS; the disease is Alzheimer disease.